Activity ID
14110Expires
September 12, 2025Format Type
EnduringCME Credit
1Fee
$0CME Provider: Clinical Care Options, LLC
Description of CME Course
With the expanding use of antipsychotic agents for the treatment of bipolar and major depressive disorder, awareness of the risk for tardive dyskinesia is vital in these patient populations. This session presents best pratices for screening, symptom assessment, and treatment with VMAT2 inhibitors.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Psychiatry and Neurology
Commercial Support?
YesNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
1. Identify risk factors for TD that increase susceptibility in older individuals
2. Implement best practices for using screening and assessment tools with patients at risk for TD
3. Interpret screening tool results to identify TD, considering patient and caregiver reports
4. Evaluate the safety, effectiveness, and pharmacologic properties of VMAT2 inhibitors for managing TD in older adults and special populations
5. Develop an individualized treatment plan for diverse patient populations with TD
Competencies
Medical Knowledge
CME Credit Type
AMA PRA Category 1 Credit
Practice Setting
Academic Medicine, Inpatient, Outpatient, Rural, Urban, VA/Military
